Literature DB >> 20473911

Gallbladder cancer: incidence and survival in a high-risk area of Chile.

Enriqueta Bertran1, Katy Heise, Marcelo E Andia, Catterina Ferreccio.   

Abstract

We assessed population incidence rates 1998-2002 and 5-year survival rates of 317 primary gallbladder cancer (GBC) entered in the population-based cancer registry in Valdivia. We analyzed GBC incidence (Poisson regression) and GBC survival (Cox regression). Cases were identified by histology (69.4%), clinical work-up (21.8%), or death certificate only (8.8%). Main symptoms were abdominal pain (82.8%), jaundice (53.6%) nausea (42.6%), and weight loss (38.2%); at diagnosis, 64% had Stage TNM IV. In the period, 4% of histopathological studies from presumptively benign cholecystectomies presented GBC. GBC cases were mainly females (76.0%), urban residents (70.3%), Hispanic (83.7%) of low schooling <4 years (64.0%). GBC standardized incidence rate per 100,000 (SIR) were all 17.5 (95%CI: 15.5-19.4), women 24.3, and men 8.6 (p < 0.00001); Mapuche 25.0, Hispanic 16.2 (p = 0.09). The highest SIRs were in Mapuche (269.2) and Hispanic women (199.6) with <4 years of schooling. Lowest SIRs were among Hispanic men (19.8) and women (21.9) with >8 years of schooling. Low schooling, female and urban residence were independent risk factors. By December 31, 2007, 6 (1.9%) cases were living, 280 (88.3%) died from GBC, 32 (10.1%) were lost of follow-up. Kaplan Meier Global 5-year survival was: 10.3%, 85% at stage I and 1.9% at stage IV; median survival: 3.4 months. Independent poor prognostic factors were TNM IV, jaundice and nonincidental diagnoses. Our results suggest that women of Mapuche ancestry with low schooling (>50 years) are at the highest risk of presenting and dying from GBC and should be the target for early detection programs.

Entities:  

Mesh:

Year:  2010        PMID: 20473911     DOI: 10.1002/ijc.25421

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Early gallbladder carcinoma has a favorable outcome but Rokitansky-Aschoff sinus involvement is an adverse prognostic factor.

Authors:  Juan C Roa; Oscar Tapia; Carlos Manterola; Miguel Villaseca; Pablo Guzman; Juan Carlos Araya; Pelin Bagci; Burcu Saka; Volkan Adsay
Journal:  Virchows Arch       Date:  2013-09-11       Impact factor: 4.064

2.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

Authors:  Mia S DeSimone; Michael Goodman; Burcin Pehlivanoglu; Bahar Memis; Serdar Balci; Juan Carlos Roa; Kee-Taek Jang; Jin-Young Jang; Seung-Mo Hong; Kyoungbun Lee; Haeryoung Kim; Hye-Jeong Choi; Takashi Muraki; Juan Carlos Araya; Enrique Bellolio; Juan M Sarmiento; Shishir K Maithel; Hector F Losada; Olca Basturk; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

3.  The Chile Biliary Longitudinal Study: A Gallstone Cohort.

Authors:  Jill Koshiol; Vanessa Van De Wyngard; Emma E McGee; Paz Cook; Ruth M Pfeiffer; Noldy Mardones; Karie Medina; Vanessa Olivo; Karen Pettit; Sarah S Jackson; Fabio Paredes; Raúl Sanchez; Andrea Huidobro; Miguel Villaseca; Enrique Bellolio; Hector Losada; Juan Carlos Roa; Allan Hildesheim; Juan Carlos Araya; Catterina Ferreccio
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897

4.  Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies.

Authors:  Jill Koshiol; Felipe Castro; Troy J Kemp; Yu-Tang Gao; Juan Carlos Roa; Bingsheng Wang; Leticia Nogueira; Juan Carlos Araya; Ming-Chang Shen; Asif Rashid; Ann W Hsing; Allan Hildesheim; Catterina Ferreccio; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Cytokine       Date:  2016-05-09       Impact factor: 3.861

5.  Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Authors:  Jill Koshiol; Yu-Tang Gao; Amanda Corbel; Troy J Kemp; Ming-Chang Shen; Allan Hildesheim; Ann W Hsing; Asif Rashid; Bingsheng Wang; Ruth M Pfeiffer; Ligia A Pinto
Journal:  Cancer Epidemiol       Date:  2018-03-16       Impact factor: 2.984

6.  Diagnosis of incidental gallbladder cancer after laparoscopic cholecystectomy: our experience.

Authors:  Alessia G Ferrarese; Mario Solej; Stefano Enrico; Alessandro Falcone; Silvia Catalano; Giada Pozzi; Silvia Marola; Valter Martino
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

7.  Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.

Authors:  Adalberto Miranda-Filho; Marion Piñeros; Catterina Ferreccio; Volkan Adsay; Isabelle Soerjomataram; Freddie Bray; Jill Koshiol
Journal:  Int J Cancer       Date:  2020-01-21       Impact factor: 7.316

Review 8.  A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy.

Authors:  Jorge Jimenez de la Jara; Gabriel Bastias; Catterina Ferreccio; Cristian Moscoso; Sofia Sagues; Camilo Cid; Eduardo Bronstein; Cristian Herrera; Bruno Nervi; Alejandro Corvalan; Ethel V Velasquez; Pamela Gonzalez; Enrique Castellon; Eva Bustamante; Sergio Oñate; Eileen McNerney; Richard Sullivan; Gareth I Owen
Journal:  Biol Res       Date:  2015-01-26       Impact factor: 5.612

Review 9.  Cancer in indigenous people in Latin America and the Caribbean: a review.

Authors:  Suzanne P Moore; David Forman; Marion Piñeros; Sdenka M Fernández; Marceli de Oliveira Santos; Freddie Bray
Journal:  Cancer Med       Date:  2013-12-03       Impact factor: 4.452

Review 10.  Gallstones: new insights into an old story.

Authors:  Evan Tiderington; Sum P Lee; Cynthia W Ko
Journal:  F1000Res       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.